REVIVA PHARMACEUTICALS HOLDINGS, INC. Quarterly Common Stock, Shares Authorized from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Reviva Pharmaceuticals Holdings, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2019 to Q3 2024.
  • Reviva Pharmaceuticals Holdings, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 115M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 115M 0 0% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 115M 0 0% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 115M 0 0% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 115M 0 0% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 115M 0 0% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 115M 0 0% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 115M 0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 115M 0 0% Dec 31, 2022 10-K 2024-04-15
Q3 2022 115M 0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 115M 0 0% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 115M 0 0% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 115M 0 0% Dec 31, 2021 10-K 2023-03-30
Q3 2021 115M Sep 30, 2021 10-Q 2021-11-15
Q2 2021 115M Jun 30, 2021 10-Q 2021-08-16
Q1 2021 115M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 115M 0 0% Dec 31, 2020 10-K 2022-03-15
Q4 2019 115M Dec 31, 2019 10-K/A 2021-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.